Press Releases News Year None202020192018201720162015201420132012 Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 | Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 | Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 | Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 | Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 | Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 | Ophthotech Reports Second Quarter 2018 Financial and Operating Results Aug 01, 2018 | Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 | Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 | Ophthotech Reports First Quarter 2018 Financial and Operating Results May 09, 2018 | Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last »
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 |
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 |
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 |
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 |
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 |
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 |
Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 |
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 |
Press Releases News Year None202020192018201720162015201420132012 Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 | Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 | Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 | Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 | Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 | Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 | Ophthotech Reports Second Quarter 2018 Financial and Operating Results Aug 01, 2018 | Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 | Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 | Ophthotech Reports First Quarter 2018 Financial and Operating Results May 09, 2018 | Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last »
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease) Oct 31, 2018 |
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 |
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 |
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 |
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 |
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 |
Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 |
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 |
